GVT
BIIB icon

Genesee Valley Trust’s Biogen BIIB Stock Holding History

Genesee Valley Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-650
Closed -$204K – 228
2017
Q3 		$204K Buy
+650
New +$192K 0.08% 212
2016
Q4 		– Sell
-984
Closed -$308K – 231
2016
Q3 		$308K Sell
984
-2
-0.2% -$592 0.19% 166
2016
Q2 		$238K Sell
986
-67
-6% -$17.7K 0.15% 197
2016
Q1 		$274K Hold
1,053
– – 0.19% 178
2015
Q4 		$323K Buy
1,053
+319
+43% +$91.7K 0.21% 157
2015
Q3 		$214K Buy
+734
New +$242K 0.14% 209

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Genesee Valley Trust's BIIB Position: Q4 2017 in Review

Genesee Valley Trust sold out of Biogen (BIIB) in Q4 2017, closing a stake of 650 shares — an estimated $204K sold.

Genesee Valley Trust first reported a position in BIIB in Q3 2015 and held it in 6 quarters. The position peaked at $323K in Q4 2015. 1,123 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Genesee Valley Trust reported no remaining Biogen position as of Q4 2017 after selling out during the quarter.
  • Genesee Valley Trust sold 650 Biogen shares in Q4 2017, an estimated $204K.
  • Genesee Valley Trust first reported a position in Biogen in Q3 2015 and held it in 6 quarters.
  • Genesee Valley Trust's Biogen position peaked at $323K in Q4 2015.
  • 1,123 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Genesee Valley Trust's 13F filing for Q4 2017, filed 6 Feb 2018.